Critical illness–related corticosteroid insufficiency
| Critical illness–related corticosteroid insufficiency | |
|---|---|
| Synonyms | CIRCI |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hypotension, shock, fever, fatigue, weakness |
| Complications | Sepsis, multiple organ dysfunction syndrome |
| Onset | During critical illness |
| Duration | Variable |
| Types | N/A |
| Causes | Critical illness, sepsis, trauma, surgery |
| Risks | Severe illness, sepsis, trauma |
| Diagnosis | ACTH stimulation test, serum cortisol levels |
| Differential diagnosis | Adrenal insufficiency, septic shock, hypothyroidism |
| Prevention | N/A |
| Treatment | Glucocorticoids, hydrocortisone |
| Medication | N/A |
| Prognosis | Variable, depends on underlying condition |
| Frequency | Common in intensive care unit patients |
| Deaths | N/A |
Critical Illness–Related Corticosteroid Insufficiency (CIRCI) is a medical condition characterized by an inadequate corticosteroid response to stress in critically ill patients. This condition is observed in individuals suffering from severe illnesses or those in intensive care units (ICUs). CIRCI leads to a range of clinical manifestations due to the body's inability to produce sufficient levels of corticosteroids, which are crucial for managing stress and inflammation.
Definition[edit]
CIRCI is defined by the presence of clinical signs of corticosteroid insufficiency in critically ill patients, despite the absence of overt adrenal disease. It is diagnosed based on a combination of clinical features and laboratory tests, including low cortisol levels or a diminished response to adrenocorticotropic hormone (ACTH) stimulation tests.
Pathophysiology[edit]
The pathophysiology of CIRCI involves a complex interplay between the hypothalamus, pituitary gland, and adrenal glands, collectively known as the HPA axis. In response to stress, the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the pituitary gland to secrete ACTH. ACTH, in turn, prompts the adrenal glands to produce corticosteroids. In CIRCI, this axis is dysregulated, leading to inadequate corticosteroid production during critical illness. Factors contributing to the development of CIRCI include direct damage to the HPA axis, altered cortisol metabolism, and tissue resistance to corticosteroids. Critical illnesses, such as severe infections, trauma, and surgeries, can trigger these disruptions.
Clinical Features[edit]
Patients with CIRCI may exhibit a wide range of symptoms, including fatigue, hypotension (low blood pressure), muscle weakness, and fever. These symptoms are nonspecific and can overlap with those of the underlying critical illness, making the diagnosis of CIRCI challenging.
Diagnosis[edit]
The diagnosis of CIRCI is primarily based on clinical judgment, supported by laboratory tests. The most commonly used diagnostic test is the ACTH stimulation test, which measures the adrenal glands' response to synthetic ACTH. A suboptimal increase in cortisol levels following ACTH administration suggests CIRCI.
Treatment[edit]
Treatment of CIRCI involves the administration of corticosteroids, such as hydrocortisone, to replace the deficient hormones. The dose and duration of corticosteroid therapy are tailored to the individual patient's needs, taking into account the severity of illness and the presence of potential side effects.
Prognosis[edit]
The prognosis of patients with CIRCI varies widely and depends on the underlying critical illness, the timeliness of diagnosis, and the effectiveness of corticosteroid replacement therapy. Early recognition and appropriate management of CIRCI can improve outcomes in critically ill patients.
Epidemiology[edit]
CIRCI is a relatively common condition among critically ill patients, although its exact prevalence is difficult to determine due to varying diagnostic criteria and study populations. It is more frequently observed in patients with sepsis, severe trauma, and major surgeries.
Conclusion[edit]
Critical Illness–Related Corticosteroid Insufficiency is a significant condition affecting critically ill patients, characterized by an inadequate corticosteroid response to stress. Early recognition, accurate diagnosis, and appropriate corticosteroid replacement therapy are crucial for managing CIRCI and improving patient outcomes.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
